Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 1, 2002Antimicrobial Agents and ChemotherapyOpen Access

Mutator Bacteria as a Risk Factor in Treatment of Infectious Diseases

View Full Paper
Ask AI
Bookmark
Share

Authors

AGAntoine GiraudUppsala UniversityIMIvan MatićCentre National de la Recherche ScientifiqueMRMiroslav RadmanMediterranean Institute for Life Sciences

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Giraud et al. (2002) studied this question.

synapsesocial.com/papers/6a82f412ef922d2380581bf9https://doi.org/10.1128/aac.46.3.863-865.2002
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Costs and Benefits of High Mutation Rates: Adaptive Evolution of Bacteria in the Mouse Gut2001 · 507 citations
  2. 2High Frequency of Mutator Strains among Human Uropathogenic Escherichia coli Isolates2002 · 181 citations
  3. 3Health and Economic Outcomes of Antibiotic Resistance in Pseudomonas aeruginosa1999 · 370 citations
  4. 4The Complete Genome Sequence of Escherichia coli K-121997 · 7,605 citations
  5. 5Proliferation of mutators in A cell population1997 · 334 citations